GLP-1 Drugs May Ease Psoriasis in Some Patients, Study Finds
A new study finds GLP-1 receptor agonists improved psoriasis in some patients, reinforcing the link between metabolic health and skin inflammation.
Section
Inflammatory Disease
Psoriasis, atopic dermatitis, hidradenitis and autoimmune skin therapeutics.
Optimizing Hidradenitis Suppurativa Care: Biologics, Combos, Surgery
Expert guidance from HCPlive focuses on optimizing HS biologics, combination therapy and surgical timing in hidradenitis suppurat…
Review reframes AD and psoriasis as dynamic immune processes
A Frontiers review reframes atopic dermatitis and psoriasis as dynamic immune processes, arguing static histopathology misses imm…
Systematic Review Probes Immune Link Between Childhood Obesity and Eczema
A systematic review examines whether obesity-driven inflammation helps drive pediatric eczema, probing shared immune pathways beh…
Wiley Review Maps Herbal Bioactives in Atopic Dermatitis Care
A Wiley review synthesizes evidence, mechanisms and pediatric safety for plant-derived bioactives in atopic dermatitis, calling f…
Fine Particulate Matter Linked to Atopic Dermatitis, Kyung Hee Study Finds
Kyung Hee University researchers report a link between fine particulate matter exposure and atopic dermatitis, adding Korean data…
Two-Thirds of Atopic Dermatitis Patients Misdiagnosed, Report Finds
Two out of three patients with atopic dermatitis are misdiagnosed, HCPLive reports — a two-thirds error rate with consequences fo…
Early Psoriatic Arthritis Screening Can Prevent Irreversible Damage
Dermatologists see psoriasis patients years before rheumatology does. Friedman argues that window is the chance to catch psoriati…
HS Management Spotlighted: Comorbidities, Expectations, Wound Care
HCPLive's latest report on hidradenitis suppurativa centers expectation-setting, comorbidity screening, and structured wound care…
Liver Function Test Elevations Rare With Biologics in Psoriasis and HS
Liver function test elevations occur rarely in psoriasis and HS patients on biologics, Dermatology Times reports — supporting str…